• Founder(s): Dr. Jörn Klinger & Dr.Marco Schmidt
  • Established: 2017
  • CEO(s): Dr. Jörn Klinger & Dr.Marco Schmidt
  • Employees: 6
  • Financial Data: Received €440.000 in funding & seeking €1.5m venture capitalist funding for next round of investment
  • Website: 

Description has the goal of making precision medicine a reality. The team of six have developed an artificial intelligence (AI) that is specifically designed for the analysis of complex interactions in biomedical data.

Their AI can recognize complex interactive patterns hidden in large amounts of data, which can help to improve drug development and bring precision medicine to patients.

Located in Potsdam, is very close to the life sciences hotspot Berlin, which is treasured by many global players.